Biohaven Shares Outstanding 2016-2024 | BHVN

Biohaven shares outstanding for the quarter ending June 30, 2024 were 0.088B, a 28.6% increase year-over-year.

  • Biohaven 2023 shares outstanding were 0.071B, a 59.14% increase from 2022.
  • Biohaven 2022 shares outstanding were 0.045B, a 13.63% increase from 2021.
  • Biohaven 2021 shares outstanding were 0.039B, a 0% decline from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Biohaven Shares Outstanding 2016-2024 | BHVN

  • Biohaven 2023 shares outstanding were 0.071B, a 59.14% increase from 2022.
  • Biohaven 2022 shares outstanding were 0.045B, a 13.63% increase from 2021.
  • Biohaven 2021 shares outstanding were 0.039B, a 0% decline from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$173B
Vertex Pharmaceuticals (VRTX)$129.4B
Gilead Sciences (GILD)$121.9B
Bristol Myers Squibb (BMY)$111B
CSL (CSLLY)$91.9B
Regeneron Pharmaceuticals (REGN)$90.6B
GSK (GSK)$76B
Argenex SE (ARGX)$35.4B
Alnylam Pharmaceuticals (ALNY)$35.1B
BioNTech SE (BNTX)$25.7B
Biogen (BIIB)$25.3B
Illumina (ILMN)$24.6B
BeiGene (BGNE)$20.1B
Moderna (MRNA)$19.3B
Incyte (INCY)$15.9B
Genmab (GMAB)$15.3B
Insmed (INSM)$12.8B
Vaxcyte (PCVX)$12.8B
BioMarin Pharmaceutical (BMRN)$12.8B
Bio-Techne Corp (TECH)$12.1B
Sarepta Therapeutics (SRPT)$11.5B
Exelixis (EXEL)$10.2B
QIAGEN (QGEN)$10.1B
Revolution Medicines (RVMD)$9.9B
Exact Sciences (EXAS)$9.9B
Intra-Cellular Therapies (ITCI)$9.6B
Bio-Rad Laboratories (BIO.B)$9.4B
Roivant Sciences (ROIV)$8.7B
Repligen (RGEN)$8.1B
Ascendis Pharma (ASND)$7.7B